ARTICLE | Distillery Therapeutics
Ophthalmic disease
December 19, 2017 8:54 PM UTC
Patient samples and mouse studies suggest inhibiting EPHX2 could help treat non-proliferative diabetic retinopathy (NPDR). In postmortem retinal tissue samples from patients, high levels of EPHX2 were...
BCIQ Company Profiles
BCIQ Target Profiles